Ropivacaine Use in Interscalene Block; What is the Minimal Effective Analgesic Concentration (MEAC 90)

Clinical trial NCT04833296 · UNKNOWN

Trial details

NCT number: NCT04833296
Sponsor: Healthpoint Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Postoperative Pain

Start date: 2021-05-01
Primary completion: 2021-09-30
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.